June 9, 2016

NIH New Forms-D Reminder (Biosketch, Assignment Request Form, Cover Letter, Authentication of Key Biologics and Chemical Resources)

As of May 25, 2016 use the New Biosketch Format for all your Key Personnel, Significant Contributors and Sub Contractors.  NIH is no longer accepting the outdated forms, therefore we will not be able to submit your proposal with outdated biosketch templates.

http://grants.nih.gov/grants/forms/biosketch.htm

You are also required to fill in the Assignment Request Form (Awarding component, study section, individuals who should not review and expertise needed) in the S2S tab of your LLeRA record. NIH receipt and referral staff will no longer look for assignment requests in the Cover Letter (do not include it in the Cover Letter), they are only looking in the PHS Assignment Request Form.

The NIH states, the “Cover Letter should still be used for any narrative information you want to relay to the receipt and referral staff, such as:

  • Reason for late application
  • Explanation of why a Subaward isn’t active in all periods of the proposed project
  • Statements regarding agency approval documents (e.g., requests over $500,000)
  • Intent to submit a video as part of the application (NOT-OD-12-141)
  • Indication that the proposed study will generate large-scale human or non-human genomic data (NOT-OD-14-111 and NOT-OD-15-027)”

In addition, Authentication of Key Biologics and Chemical Resources, has its own upload tab in your Research Plan section—NIH suggest one page limit.  If your research involves biologics or chemical resources the NIH instructs to: “Briefly describe methods to ensure the identity and validity of key biological and/or chemical resources used in the proposed studies.

  • Key biological and/or chemical resources may or may not be generated with NIH funds and: 1) may differ from laboratory to laboratory or over time; 2) may have qualities and/or qualifications that could influence the research data; and 3) are integral to the proposed research. These include, but are not limited to, cell lines, specialty chemicals, antibodies, and other biologics
  • Standard laboratory reagents that are not expected to vary do not need to be included in the plan. Examples are buffers and other common biologicals or chemicals.”

If you are working on a multiple Principal Investigator proposal don’t forget the Leadership Plan and if you are submitting a Clinical Trial proposal you must compose a Data Safety Monitor Plan/Board. 

For additional information or clarification contact Cindy Dickson, x44571 or cdickson@llu.edu

Share